Ditropan

This page contains recent news articles, when available, and an overview of Ditropan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Ditropan
(when available)

Pharmacology and use:
Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer. For the treatment of overactive bladder

Mechanism Of Action:
Oxybutynin exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. No blocking effects occur at skeletal neuromuscular junctions or autonomic ganglia (antinicotinic effects).

News Articles on Oxybutynin

A roundup of 2009's FDA-approved items  -  ‎Dec 29, 2009‎
Gelnique (oxybutynin) gel: It's the skin cream version of the oral drug called Ditropan, which treats overactive bladder, incontinence or urgency. ... Herald & Review

Generic Name: Oxybutynin, Ditropan XL  -  ‎Nov 11, 2009‎
Ditropan (generic name: Oxybutynin) is used to decrease the urgency and the frequency of urination. Ditropan is used to control urgent, frequent, ... Pattaya Daily News

What Is Enuresis? What Is Nocturnal Bedwetting?  -  ‎Nov 4, 2009‎
If the child has a small bladder, an anticholinergic drug such as oxybutynin (Ditropan) or hyoscyamine (Levsin) may help reduce bladder contractions and ... Medical News Today

J&J loses appeal against IMPAX' generic version of Ditropan …  -  Sep 7, 2006
IMPAX' version of Ditropan is one of 12 products covered under a strategic alliance entered into in June 2001 with a subsidiary of Teva Pharmaceutical ... Forbes

J&J's Bladder Drug Ditropan Needs Stronger Warnings, US Says  -  Apr 9, 2007
By Catherine Larkin. April 9 (Bloomberg) -- Johnson & Johnson's Ditropan, used to calm an overactive bladder, should have stronger warnings that the drug ... Bloomberg

Impax OK'd on generic Ditropan  -  May 9, 2007
HAYWARD, Calif., May 9 (UPI) -- US generic firm Impax said Wednesday it has received approval to market a generic version of Alza's Ditropan XL. ... United Press International

Mylan Labs quarterly profitmore than doubles  -  Feb 1, 2007
N said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ... Reuters

IMPAX Prevails in Alza's Lawsuit Related to Generic Version of Ditropa...  -  Sep 29, 2005
According to NDCHealth, sales of Ditropan XL tablets were $395 million, with the 15 mg accounting for $66 million, in the 12 months ended July 2005. ... RedOrbit

Drug adherence poor in women with urinary trouble  -  Dec 25, 2008
Two examples of anticholinergic drugs that are often prescribed for urinary incontinence are oxybutynin (Ditropan) and tolterodine (Detrol). ... Reuters

FDA Clears Mylan Bladder Drug  -  Nov 10, 2006
Mylan (MYL) got Food and Drug Administration approval to sell a generic version of Alza's Ditropan extended-release tablets for treating bladder ailments. ... TheStreet.com - TheStreet.com (subscription)

Bladder and dementia therapy may be incompatible  -  Jun 5, 2008
About 10 percent of the residents were also taking either oxybutynin (Ditropan) or tolterodine (Detrol), the two most often prescribed drugs for urinary ... Reuters India

The Allure Of Impax  -  Mar 14, 2005
In February, its Ditropan XL for urinary incontinence got a tentative OK It has 16 applications pending, with five tentatively approved. ... BusinessWeek

Urinary incontinence  -  Apr 28, 2006
Examples include tolterodine (Detrol), oxybutynin (Ditropan) and ... Or you may want to try an extended-release form of oxybutynin (Ditropan XL) or ... cnn.com

Allergan predicts big growth for bladder drug  -  Feb 7, 2008
N) Ditropan XL, and Enablex, sold by Novartis (NOVN.VX) and Procter & Gamble Co. (PG.N). Allergan in January launched a new once-daily form of its bladder ... Reuters

FDA approves generic Ditropan East Bay Business Times  -  Feb 2, 2005
Federal regulators have tentatively approved a generic version of a urinary incontinence drug developed by Hayward's Impax Laboratories Inc., ... East Bay Business Times

Citi Sets Barr Higher, Mylan Lower  -  Oct 31, 2006
While Swanson acknowledges that his Mylan downgrade comes before the expected approval of its generic version of the overactive-bladder treatment Ditropan ... TheStreet.com - TheStreet.com (subscription)

Article: FDA: Bladder drug needs stronger warning - The Record...  -  Apr 10, 2007
Johnson & Johnson's Ditropan, used to calm an overactive bladder, ... Article: ALZA's Ditropan XL Approved for Treatment of Overactive ... ... Pay-Per-View - The Record - HighBeam Research

Drug adherence poor in women with urinary trouble  -  Dec 26, 2008
Two examples of anticholinergic drugs that are often prescribed for urinary incontinence are oxybutynin (Ditropan) and tolterodine (Detrol). ... Indian Express

Impax drug gets final FDA approval  -  Nov 10, 2006
Ditropan XL is sold by Mountain View-based Alza Corp. to treat urge urinary ... This formulation of Ditropan XL (Oxybutynin Chloride) comes out of a ... Bizjournals.com

Bladder Infection Drug, Ditropan Could Trigger Hallucinations in Both...  -  Apr 10, 2007
Washington - The Food and Drug Administration has warned that Ditropan, a drug employed to remedy overactive-bladder conditions in children and adults could ... MedIndia

… to Appeal US District Court Decision on DITROPAN XL(R) (Oxybutynin...  -  Sep 28, 2005
ALZA Corporation to Appeal US District Court Decision on DITROPAN XL(R) (Oxybutynin Chloride) Patent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Appeals court rules for Mylan on Ditropan.  -  Sep 7, 2006
PITTSBURGH (AFX) - Drug maker Mylan Laboratories Inc. said Thursday that a federal appeals court ruled in its favor in a patent dispute with Johnson ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

… ; US FDA grants tentative approval for generic version of Ditropan...  -  Feb 28, 2005
Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... US sales of Ditropan XL were approximately $410 million in the 12 months ended ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Mylan Says Fiscal 2007 Earnings Exceeded Its Forecast  -  Apr 10, 2007
Mylan specializes in copies of brand-name medicines that are difficult to make, such as Johnson & Johnson's Duragesic pain patch and Ditropan XL bladder ... Bloomberg

Bladder spasm at 3 am, when should I give Ditropan  -  Dec 27, 2008
My husband who is dying from Brain cancer has a catheter and each night about 3 am has bladder spasm, believing he has to urinate and can't. ... HealthCentral.com

FDA approves generic Impax drug  -  Dec 18, 2006
In November, the FDA approved the Hayward company's generic formulation of Urecholine, a urinary drug and its generic version of the drug Ditropan XL in ... Bizjournals.com

IMPAX's ANDA for generic of Ditropan XL gets tentative FDA nod  -  Feb 3, 2005
US FDA has granted tentative approval to IMPAX Laboratories' Abbreviated New Drug Application (ANDA) for a generic version of Ditropan XL (Oxybutynin ... pharmabiz.com

Yoga helps women 65 and older, study says  -  Apr 28, 2008
...drugs called anticholinergics, including drugs for high blood pressure, asthma, Parkinson's disease and incontinence drugs such as Detrol and Ditropan. ... $2.95 - Fort Worth Star-Telegram - NewsBank

Notebook: Medicare In Nursing Homes  -  May 9, 2006
Later the insurance company offers Ditropan XL, which is extended release oxybutinin, but Kerr wants no part of it. What did I take from watching Kerr fight ... CBS News

… District Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (...  -  Oct 11, 2007
IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. 10-11-2007) IN RE: DITROPAN XL ANTITRUST LITIGATION This Order Relates to: ALL CASES. CASE NO. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

… District Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (...  -  Apr 17, 2006
IN RE DITROPAN XL ANTITRUST LITIGATION (JPML 2006) 429 F. Supp.2d 1364 IN RE DITROPAN XL ANTITRUST LITIGATION. City of Fargo Health Trust Fund v. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Mylan, J&J reach agreements on Ditropan  -  Dec 21, 2005
AP. NEW YORK - Mylan Laboratories Inc. and Johnson & Johnson said Tuesday that they entered certain supply agreements for generic sales of J&J's Ditropan ... $2.95 - Observer-Reporter - NewsBank

… District Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (...  -  May 11, 2007
IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. 2007) 529 F. Supp.2d 1098 IN RE: DITROPAN XL ANTITRUST LITIGATION This Order Relates to: ALL CASES. CASE NO. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

… ; US FDA grants tentative approval for generic version of Ditropan...  -  Mar 4, 2005
Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... US sales of Ditropan XL were approximately $410 million in the 12 months ended ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

… District Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (...  -  Nov 5, 2007
IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. 11-5-2007) IN RE: DITROPAN XL ANTITRUST LITIGATION This Document Relates to All Actions. No. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Vesicare, Tarceva.(New & Approved)  -  Jan 1, 2005
None of the newer agents have proved to be more effective than Ditropan ... In addition to Sanctura, Ditropan, available in generic formulations, ... Free with registration - Skin & Allergy News - AccessMyLibrary.com

Healthcare Companies Making News!  -  May 9, 2007
Alza Pharmaceuticals markets Ditropan XL for the treatment of urge ... According to the announcement, the Company's version of generic Ditropan XL is one of ... Free with registration - M2 Presswire - AccessMyLibrary.com

IMPAX'S GENERIC DITROPAN XL APPROVED BY FDA  -  Nov 14, 2006
Impax Laboratories announced that the FDA has granted final approval to its abbreviated new drug application (ANDA) for a generic version of Ditropan XL ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones

Healthy Dose: Incontinence drugs and memory  -  Apr 25, 2008
The drugs included the incontinence drugs, such as Detrol and Ditropan, as well as some of the drugs used to treat high blood pressure, ... Porterville Recorder

Bladder Medication May Lead to Some Memory Loss  -  May 25, 2006
Kay found that those taking Ditropan XL scored significantly worse on the memory tests compared with those taking Enablex or placebo. ... Daily of the University of Washington - The Daily of the University of Washingto...

Tentative FDA OK for IMPAX generic Ditropan.(Food and drug …  -  Feb 7, 2005
IMPAX Laboratories says that the US Food and Drug Administration has granted tentative approval for the company's Abbreviated New Drug Application for a ... $4.95 - Pharma Marketletter - ECNext

Paparo v. Ortho McNeil Pharmaceutical, No. 05-81044-CIV-RYSKAMP/ …  -  Jan 10, 2007
Plaintiff claims that ingestion of Ditropan XL caused her to lose her teeth and ... Plaintiff recalls that such warned that Ditropan XL "causes dry mouth. ... $2.95 - U.S. District Court, Southern District... - VersusLaw

Press Release: National Association for Female Executives (NAFE) …  -  Jan 25, 2005
They then received either Ditropan XL once a day in the morning ... PR Newswire. Article: ALZA's Ditropan XL Approved for Treatment of ... ... Pay-Per-View - PR Newswire - HighBeam Research

… District Court Opinions - IN RE DITROPAN XL ANTITRUST LITIGATION (...  -  Jul 26, 2007
IN RE DITROPAN XL ANTITRUST LITIGATION (NDCal. 7-26-2007) IN RE: DITROPAN XL ANTITRUST LITIGATION This Order Relates to: ALL CASES. CASE NO. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Press Release: Mylan Receives Final FDA Approval for Oxybutynin …  -  Nov 10, 2006
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL(R) Extended-release Tablets. Ditropan XL(R) had U.S. sales of ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Mylan Announces Supply Agreement with Ortho-McNeil …  -  Dec 20, 2005
Pharmaceutical, Inc. markets DITROPAN XL in the U.S. and ALZA ... PR Newswire. Article: Ditropan XL a Significant Advance in Treating Urge ... ... Pay-Per-View - PR Newswire - HighBeam Research

Is Your Bladder Out Of Control?  -  Mar 5, 2006
The most widely used are oxybutynin (marketed as Ditropan), tolterodine (Detrol LA), trospium (Sanctura), darifenacin (Enablex) and solifenacin (VESIcare). ... Parade Magazine

J&J's Ditropan to get stronger warnings.(Johnson & Johnson)(Brief...  -  Apr 16, 2007
The US Food and Drug Administration says that the warning label on global health care major Johnson & Johnson's overactive bladder treatment Ditropan ... $4.95 - Pharma Marketletter - ECNext

Generic Drugs; US FDA grants tentative approval for Oxybutynin...  -  Feb 14, 2005
Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL, and as such, the company may be eligible for ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

US Advertising Spending Rose 4.6% in 2006, Nielsen Monitor-Plus …  -  Mar 19, 2007
Johnson & Johnson cut back overall spending on a number of brands including Orthoevra and Ditropan. Top 10 Advertisers % Change 2005 vs. ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: IMPAX Receives Final FDA Approval. - M2 Presswire | …  -  Nov 10, 2006
Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary ... U.S. sales of Ditropan XL 15 mg were approximately $58 million in the 12 ... Pay-Per-View - M2 Presswire - HighBeam Research

Article: The right message, better results: understanding--and...  -  Apr 1, 2007
Ditropan XL minimizes first-pass metabolism by ... day system. The important lesson for Ditropan XL (oxybutynin chloride) was that drug ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Press Release: Mylan Receives Final FDA Approval for Oxybutynin …  -  Nov 13, 2006
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Ditropan XL had U.S. sales of ... Pay-Per-View - M2 Presswire - HighBeam Research

National Association for Female Executives (NAFE) Launches Healthcare...  -  Jan 25, 2005
Many overactive bladder sufferers are being successfully treated with prescription medications, such as DITROPAN XL(R) (oxybutynin chloride). ... $4.95 - PR Newswire - ECNext

DETRUSITOL...E DITROPAN - Salute maschile  -  Mar 6, 2005
...essendo paraplegica, ho una vescica neurologica...è da molto tempo che non faccio più un'esame di urodinamica, l'ultimo l'ho eseguito dieci anni fa. ... Dica 33

Press Release: Pharma Industry Study Finds Cadient Developed Web …  -  Jun 6, 2006
Ditropan XL Web Site Has Highest Success Rate of All Conditions and Web Sites ... "Our strategy for the Ditropan XL site was centered on removing the stigma ... Pay-Per-View - PR Newswire - HighBeam Research

Urinary Incontinence Medications - Urinary Incontinence Health …  -  Aug 12, 2008
Extended-release versions of oxybutynin (Ditropan XL) and tolterodine ... Oxybutynin (Ditropan X) is approved for pediatric use in children ages 6 and older ... New York Times

Oxybutynin may get a label rewrite, FDA says.  -  May 1, 2007
Ditropan XL, the extended-release formulation, is approved for children aged 6 years and older with detrusor overactivity associated with a neurologic ... Free with registration - Pediatric News - AccessMyLibrary.com

Dans le magazine en ce moment :  -  Oct 3, 2006
...si je ne devrais pas... sur le site de Psyenfant.com, ils parlent d'un médicament qui a l'air efficace : le ditropan... parlez-en à votre médecin... ... E-Santé.fr

He only has incontinence when driving in a car. Does he have to take ...  -  Oct 13, 2008
I also took Ditropan for a while. It only made it worse. After I quit taking the Ditropan, the doctor also had be go pee every two hours and then pee again ... HealthCentral.com

The right message, better results: understanding--and improving--the ...  -  Apr 1, 2007
Analysis showed that Ditropan XL would need to deliver 15 percent more ... Other messages were less impactful: the dosage message for Ditropan XL had little ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Overactive Bladder Drugs Only Modestly Effective (press release)  -  Oct 25, 2006
The report finds that none of the five drugs - oxybutynin (Ditropan, Ditropan XL and Oxytrol, a skin patch); tolterodine (Detrol, Detrol LA); ... Natural News.com

Newer agents for the management of overactive bladder.(Clinical...  -  Dec 15, 2006
Ditropan (oxybutynin chloride) [Prescribing information]. ... Extended-release formulations of oxybutynin A 23-31 (Ditropan) and tolterodine (Detrol) are ... $4.95 - American Family Physician - ECNext

Comments on: "Pre-Dementia" On The Rise, Doctors Say - CBS News  -  Jul 29, 2008
There are some warnings about Ditropan and dementia. There are 80 or so causes of dementia. Another med has led to Alzheimer''s misdiagnosis...statins. ... CBS News

Milwaukee Journal Sentinel : DRUG CAPSULE WHAT YOU SHOULD …  -  Feb 27, 2006
What it does: Ditropan XL is a once-daily controlled-release tablet ... Interactions: Ditropan XL will add to the effects of alcohol and medicines that slow ... $2.95 - Milwaukee Journal Sentinel - NewsBank

Loislaw Federal District Court Opinions - ALZA CORPORATION v. …  -  Sep 27, 2005
Therefore, its infringement argument marshals evidence of (1) bioequivalence data from Mylan's accused product and Ditropan XL, and (2) in vitro testing of ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Press Release: Mylan Laboratories (MYL) SqueezeTrigger Price Is …  -  Sep 28, 2005
Short Sellers Down Approximately $6.35 Million After Mylan Wins Ditropan Case. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research

Drug Monitoring in Children Led to Recommendations on Safety  -  Sep 2, 2008
...were Roche Holding AG's Tamiflu treatment for influenza and Johnson & Johnson's Ditropan for overactive bladders and Duragesic patches for pain. ... Bloomberg

Allergan expands bladder role with Esprit deal  -  Sep 19, 2007
N) Ditropan XL, and Enablex, sold by Novartis (NOVN.VX) and Procter & Gamble Co (PG.N). Allergan said it aims to launch Sanctura XR in the first quarter of ... Reuters

Weight loss probably not due to drinking gallons of water  -  Apr 20, 2006
I recently began to take Ditropan XL at night, and it works well for me. ... Ditropan can slow sweating, so don't get overheated in hot weather. ... SouthCoastToday.com - SouthCoastToday.com

What to do if you have an overactive bladder  -  Feb 7, 2006
The medication that has been used for the longest time is oxybutynin (Ditropan). This originally came in the form of a short-acting tablet that had ... msnbc.com

Heinz promotes Moran, while debt rating lowered  -  Dec 21, 2005
Analyst Tim Chiang estimated a Ditropan launch could boost Mylan earnings by 10-15 cents per share in the first year. Thomas F. McKnight, a 25-year Neville ... Pittsburgh Tribune-Review

Atlanta health, diet and fitness news | ajc.com  -  Sep 5, 2006
People taking any of the five drugs -- oxybutynin (Ditropan, Ditropan XL and Oxytrol, a skin patch); tolterodine (Detrol, Detrol LA); trospium (Sanctura); ... Atlanta Journal Constitution

Hot Stocks to Watch! November 13, 2006.  -  Nov 13, 2006
Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary ... US sales of Ditropan XL 15 mg were approximately $58 million in the 12 months ... $4.95 - M2 Presswire - ECNext

Loislaw Federal District Court Opinions - YOST v. BARNHART (SDCal. …  -  Dec 29, 2005
...(Id.) He prescribed another month of gradually increasing Ditropan. (Id.) In December of 2001, Dr. Guerena increased the dosage of Plaintiff's Ditropan and ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

SENS. KOHL, LEAHY INTRODUCE BILL TO STOP FRIVOLOUS CITIZEN …  -  Sep 28, 2006
Mylan laboratories, the maker of Ozybutynin, estimates that Ditropan XL generates more than $1.8 million in sales, daily. ... Pay-Per-View - US Fed News - Factiva, from Dow Jones

Article: Oxybutynin may get a label rewrite, FDA says. - Pediatric...  -  May 1, 2007
Ditropan XL, the extended-release formulation, is approved for children aged 6 years and older with detrusor overactivity associated with a neurologic ... Pay-Per-View - Pediatric News - HighBeam Research

مستشارك الطبي  -  Jan 15, 2006
دواء Ditropan Ùˆ Detrol يعملان على تهدئة المثانة العصبية حتى تقوم بوظيÙ?Ø© التخزين وتختلÙ? ... الرياض

AAN: Common Anticholinergics Speed Cognitive Decline  -  Apr 18, 2008
The most common were the urinary incontinence drugs tolterodine (28.57%) and oxybutynin (21.01% Ditropan and 21.01% Ditropan XL). ... MedPage Today

Store glasses will help you read tiny type, won't hurt the eyes ;...  -  Nov 25, 2005
You can also try drugs such as Tofranil, DDAVP or Ditropan, Detrol, Vesicare, Sanctura or Enablex. But bedwetting may recur if the drugs are stopped. ... Pay-Per-View - The Sun - ProQuest Archiver

Court of Appeals rules in favor of Mylan in Oxybutynin patent case  -  Sep 11, 2006
Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid. ... News-Medical.net

Neuromed Licenses Phase 3 Chronic Pain Product from ALZA …  -  Apr 24, 2007
CONCERTA(R), DITROPAN XL(R), OROS(R), and PUSH-PULL(TM) are trademarks of ALZA Corporation; JURNISTA(TM) is a trademark of Janssen-Cilag; PROCARDIA XL(R) is ... Free with registration - PR Newswire - AccessMyLibrary.com

Straits Gold Pty Ltd withdraws offer for Goldminco Corp-Tenements(2) ...  -  Sep 2, 2008
Ortho Biotech Inc.: Doxil; Ortho-McNeil Pharmaceuticals Inc.: Ditropan XL, Levaquin, Regranex… Storms continue. (F-N) · Storms continue. ... Pay-Per-View - deals - Alacra Store

New Data Show Overactive Bladder Therapy Enablex(R) Does Not Impair …  -  May 23, 2006
In contrast, treatment with Ditropan XL(R)(i) (oxybutynin extended-release ... Enablex and Ditropan XL are indicated for the treatment of overactive bladder ... Free with registration - PR Newswire - AccessMyLibrary.com

Schaeffer's S&P 500 Index Hot Stocks Features Paychex, Mylan …  -  Sep 28, 2005
A federal district court in Northern West Virginia ruled that the company has not infringed on a patent for Ditropan XL extended-release tablets, ... businesswire.com

Mylan Announces Supply Agreement with Ortho-McNeil on Oxybutynin.  -  Dec 20, 2005
Ortho-McNeil has also agreed to supply Mylan with a generic version of DITROPAN XL(R) sooner than a final appellate court decision if another generic ... Free with registration - PR Newswire - AccessMyLibrary.com

still in diapers 24/7  -  Dec 29, 2007
...couldn't find anything wrong with my bladder but she thinks it's overactivebladder so she put me on ditropan of 10mg.i try ditropan it only seems to... ... HealthCentral.com

Can you take it? See AOPA's updated list of medications  -  Jun 26, 2006
The FAA does not allow Ditropan or Ditropan XL, which is used to treat bladder spasms. Search AOPA's database to see if you are taking any medication that ... AOPA Pilot

Obviousness: Motivation to Combine References Found in Expert …  -  Sep 6, 2006
Alza's formulation is sold as Ditropan XL®. Mylan wants to sell a generic version and challenged the patent, and the district court obliged by finding the ... Patently-O

Crowded Field of OAB Medications  -  Aug 11, 2006
Sanctura XR joins the ranks of several once daily medications for OAB including Detrol-LA, Ditropan XL, Enablex, and Vesicare. While these Phase III trials ... Gerson Lehrman Group

Product News from the 11/14/06 News Brief  -  Nov 14, 2006
The FDA has granted Mylan Laboratories approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Medical Marketing & Media - Medical Marketing and Media

US Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent …  -  Oct 9, 2006
Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid. ... ag-IP-news Agency

Tolerability, safety vary among antimuscarinic agents: treatments for...  -  May 15, 2005
The extended-release formulation of oxybutynin (Ditropan XL), immediate-release tolterodine, and extended-release tolterodine had favorable tolerability ... Free with registration - Urology Times - AccessMyLibrary.com

Skip meds first in treating agitation.(care and treatment)  -  Jun 1, 2006
Ditropan, which is used for urinary incontinence, is one of the biggest offenders, in Dr. Cheong's view. "I always tell patients and their families: 'Look, ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com

Perils of corporate growth through takeovers  -  Nov 3, 2005
Two of Alza's big products, the attention-deficit treatment Concerta and the urinary incontinence treatment Ditropan XL, face generic threats. ... New York Times

Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended- …  -  Nov 13, 2006
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Ditropan XL had US sales of approximately ... $4.95 - M2 Presswire - ECNext

Mylan Labs in Deal to Buy German Generic Drug Unit  -  May 14, 2007
Mylan specializes in copies of brand-name medicines that are difficult to make, like Johnson & Johnson's Duragesic pain patch and Ditropan XL bladder ... New York Times

Generic Drugs; US FDA grants tentative approval for Oxybutynin...  -  Feb 15, 2005
Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL, and as such, the company may be eligible for ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Generic Drugs; US FDA grants tentative approval for Oxybutynin...  -  Feb 20, 2005
Mylan believes it is the first generic drug company to file ANDAs with the FDA for 5 mg and 10 mg Ditropan XL, and as such, the company may be eligible for ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones

Agitation in dementia: start Tx nonmedically: confounding environmenta...  -  Jun 1, 2006
Ditropan, which is used for urinary incontinence, is one of the biggest offenders, in Dr. Cheong's view. "I always tell patients and their families: 'Look, ... Pay-Per-View - Family Practice News - HighBeam Research

Press Release: PPD Reports That ALZA Issued News Release on …  -  Oct 26, 2005
DITROPAN XL ... bladder. The suit was initiated by ALZA Corporation on May 2, 2003 in response to Mylan ... PR Newswire. Article: Johnson & Johnson and ALZA ... Pay-Per-View - PR Newswire - HighBeam Research

Question-and-answer session.  -  Sep 1, 2007
Ditropan XL [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc; revised June 2004. (24.) Nitti VW, Sanders S, Staskin DR, et al. ... $4.95 - Urology Times - ECNext

Selecting medications for the treatment of urinary incontinence.  -  Jan 15, 2005
The anticholinergic agents oxybutynin (Ditropan; Oxytrol) and tolterodine (Detrol) are used widely to treat urge incontinence. These medications are not, ... $4.95 - American Family Physician - ECNext

Brand Names/Synonyms:
Ditropan is also known by the following brand names and/or synonymsCCRIS 1923; CHEMBANK1678; Ditropan; Ditropan Xl; Ditropan Xl;; HSDB 3270; Oxibutinina [Inn-Spanish]; Oxibutyninum; Oxybutinin; Oxybutynin; Oxybutynin Base; Oxybutynin Chloride; Oxybutynin Hydrochloride; Oxybutynine [Inn-French]; Oxybutyninum [Inn-Latin]; Oxytrol

Drug Category:
Ditropan is categorized under the following by the FDA: Anticholinergic Agents; Antispasmodics; Genitourinary Smooth Muscle Relaxants; ATC:G04BD04

Dosage Forms:
PATCH; SYRUP; TABLET; TABLET (EXTENDED-RELEASE)

Absorption:
Rapidly absorbed from gastrointestinal tract.

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
4-diethylaminobut-2-ynyl2-cyclohexyl-2-hydroxy-2-phenyl-ethanoate





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy